BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2025 9:11:35 AM | Browse: 147 | Download: 560
 |
Received |
|
2025-04-08 13:19 |
|
Peer-Review Started |
|
2025-04-08 13:19 |
|
First Decision by Editorial Office Director |
|
2025-04-23 11:47 |
|
Return for Revision |
|
2025-04-23 11:47 |
|
Revised |
|
2025-05-01 06:11 |
|
Publication Fee Transferred |
|
2025-05-08 05:55 |
|
Second Decision by Editor |
|
2025-06-26 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-03 07:37 |
|
Articles in Press |
|
2025-07-03 07:37 |
|
Edit the Manuscript by Language Editor |
|
2025-07-06 20:07 |
|
Typeset the Manuscript |
|
2025-07-15 14:51 |
|
Publish the Manuscript Online |
|
2025-07-24 09:11 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Raisa A Aringazina, Afshin Zare, Seyyed Mojtaba Mousavi, Nurgul Abenova, Nadiar Maratovich Mussin and Amin Tamadon |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Clinical Variants of Metabolic Syndrome and Hormonal Mechanisms of its Formation in the Residents of Aktobe City |
8/5-1-04/1-36/1 |
|
| Corresponding Author |
Amin Tamadon, Full Professor, PhD, Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, No. 60 Maresiev Street, Aktobe 030012, Kazakhstan. amintamaddon@yahoo.com |
| Key Words |
Type 2 diabetes mellitus; Metabolic disorders; Obesity; Insulin lessen; Insulin resistance; Cell therapy; Mesenchymal stem cell |
| Core Tip |
This comprehensive review explores the potential of mesenchymal stem cell (MSC)-based therapies, both autologous and allogeneic, for treating type 2 diabetes mellitus. The study evaluates the safety, efficacy, and therapeutic benefits of MSCs, highlighting improvements in glycemic control, reductions in insulin requirements, and enhanced β-cell function. While MSC-based therapies show promising results with minimal adverse effects, challenges remain in standardizing treatment protocols. Future research should aim to refine these therapies and assess their long-term effects through large-scale clinical trials. |
| Publish Date |
2025-07-24 09:11 |
| Citation |
Aringazina RA, Zare A, Mousavi SM, Abenova N, Mussin NM, Tamadon A. Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis. World J Stem Cells 2025; 17(7): 108202 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i7/108202.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i7.108202 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
